Abstract
Aging constitutes an inevitable decline in vitality, representing a phenomenon that affects the population since the advent of vaccination and the doubling of life expectancy at birth. Preventive medicine stands as the cornerstone of life-saving efforts, offering an opportunity that is shaped by factors such as gender, financial resources, health consciousness, and individual decisions. It has been observed that males tend to experience the onset of chronic illnesses at an earlier stage than females, leading to a shorter life expectancy for males. While this traditional assumption may persist, recent findings in gender-specific mortality rates have revealed a significant reversal. A notable shift in the modern dynamics of gender-based mortality has been attributed to contemporary interventions, which appear to be pivotal in reducing this disparity. This analysis focuses on deaths related to circulatory failure, their comorbidity, and the early diagnosis of diseases in order to examine the Pandora's box hypothesis of gender differences and identify the statistical frailty component affecting mortality selection. The empirical findings of this analysis indicate that patients experiencing renal and circulatory failure face a mortality risk that is at least 10% higher than those with circulatory failure alone. Furthermore, the temporal changes in mortality dynamics suggest that males are reaping greater benefits from current life-extending techniques. These results strongly imply that longitudinal studies should incorporate transplant-related data to obtain a more robust hazard ratio for clinical evaluation.
Reference49 articles.
1. Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA, Centers for Disease Control and Prevention (CDC). CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. MMWR supplements. 2014 Oct 31;63(4):3–27.
2. Kendir C, van den Akker M, Vos R, Metsemakers J. Cardiovascular disease patients have increased risk for comorbidity: A cross-sectional study in the Netherlands. Eur J Gen Pract. 2017 Nov 23;24(1):45–50.
3. Nayor M, Enserro DM, Xanthakis V, Larson MG, Benjamin EJ, Aragam J, et al. Comorbidities and Cardiometabolic Disease: Relationship With Longitudinal Changes in Diastolic Function. J Am Coll Cardiol HF. 2018 Mar 26;6(4):317–25.
4. Collins AJ. Cardiovascular Mortality in End-Stage Renal Disease. The American Journal of the Medical Sciences. 2003 Apr 1;325(4):163–7.
5. Melonie Heron. Deaths: Leading Causes for 2017 [Internet]. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES: Centers for Disease Control and Prevention; 2017 Mar [cited 2019 Dec 21] p. 77. Report No.: 68; 6. Available from: https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm